Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Financial Flexibility Index
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Financial Flexibility Index of 0.59x as of December 2025. Free cash flow of CN¥468.43 Million (operating CF CN¥345.31 Million minus capex CN¥123.12 Million) represents 1% of total liabilities (CN¥797.40 Million). Also explore net asset growth rate of Jiangsu Hualv Biological Technology Co.L to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu Hualv Biological Technology Co.Ltd. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. Check 300970 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year free cash flow to debt coverage for Jiangsu Hualv Biological Technology Co.Ltd.. For the full company profile including market capitalisation, see Jiangsu Hualv Biological Technology Co.L market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | CN¥468.43 Million | CN¥345.31 Million | CN¥797.40 Million | ▲ +13.7% |
| 2024 | 0.52x | CN¥406.01 Million | CN¥137.80 Million | CN¥786.12 Million | ▼ -27.2% |
| 2023 | 0.71x | CN¥390.83 Million | CN¥166.67 Million | CN¥551.03 Million | ▼ -44.8% |
| 2022 | 1.28x | CN¥587.75 Million | CN¥179.84 Million | CN¥457.83 Million | ▲ +96.2% |
| 2021 | 0.65x | CN¥287.17 Million | CN¥83.08 Million | CN¥438.92 Million | ▼ -47.4% |
| 2020 | 1.24x | CN¥390.05 Million | CN¥199.09 Million | CN¥313.67 Million | ▲ +11.6% |
| 2019 | 1.11x | CN¥312.51 Million | CN¥213.96 Million | CN¥280.52 Million | — |